APOLIPOPROTEIN B IS RELATED TO METABOLIC SYNDROME INDEPENDENTLY OF LDL-CHOLESTEROL IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Lim, Y. -H. [1 ]
Yoo, S. Y. [1 ]
Chin, S. O. [1 ]
Lee, S. A. [1 ]
Koh, G. P. [1 ]
机构：
[1] Jeju Natl Univ Hosp, Internal Med, Jeju, South Korea
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70317-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO022
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [11] LDL-cholesterol/apolipoprotein B ratio is an independent predictor of incident metabolic syndrome in middle-aged men
    Kim, B. J.
    Kwon, C. H.
    Kang, J. H.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1013 - 1013
  • [12] Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
    Eliot A. Brinton
    Joseph Triscari
    Philippe Brudi
    Erluo Chen
    Amy O. Johnson-Levonas
    Christine McCrary Sisk
    Rae Ann Ruck
    Alexandra A. MacLean
    Darbie Maccubbin
    Yale B. Mitchel
    Lipids in Health and Disease, 15
  • [13] Statin Adherence and Treatment LDL-Cholesterol Response in Type 2 Diabetes Patients
    de Vries, Dianna
    Voorham, Jaco
    Hak, Eelko
    Denig, Petra
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 322 - 323
  • [14] Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol
    Contois, John H.
    Langlois, Michel R.
    Cobbaert, Christa
    Sniderman, Allan D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (15):
  • [15] Total variation of LDL-cholesterol and apolipoprotein B/Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks
    Coskun, Abdurrahman
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2007, 7 (03): : 331 - 332
  • [16] Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome
    Satoh, Noriko
    Wada, Hiromichi
    Ono, Koh
    Yamakage, Hajime
    Yamada, Kazunori
    Nakano, Tameo
    Hattori, Masakazu
    Shimatsu, Akira
    Kuzuya, Hideshi
    Hasegawa, Koji
    CIRCULATION JOURNAL, 2008, 72 (06) : 932 - 939
  • [17] New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
    Nurmohamed, Nick S.
    Navar, Ann Marie
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (12) : 1564 - 1575
  • [18] Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
    Skoczynska, Anna
    Turczyn, Barbara
    Wojakowska, Anna
    Kreczynska, Boguslawa
    Skoczynska, Marta
    Wojtas, Kamila
    OPEN MEDICINE, 2015, 10 (01): : 138 - 151
  • [19] Soy Protein Reduces Serum LDL Cholesterol and the LDL Cholesterol:HDL Cholesterol and Apolipoprotein B:Apolipoprotein A-I Ratios in Adults with Type 2 Diabetes
    Pipe, Elizabeth A.
    Gobert, Colleen P.
    Capes, Sarah E.
    Darlington, Gerarda A.
    Lampe, Johanna W.
    Duncan, Alison M.
    JOURNAL OF NUTRITION, 2009, 139 (09): : 1700 - 1706
  • [20] Effects of extended-release niacin/laropiprant (ERN/LRPT) on apolipoprotein (apo) B, LDL-cholesterol, and non-HDL-cholesterol targets in patients with type 2 diabetes
    Mitchel, Y.
    Brinton, E.
    Triscari, J.
    Chen, E.
    Johnson-Levonas, A. O.
    Ruck, R.
    MacLean, A.
    Maccubbin, D.
    DIABETOLOGIA, 2012, 55 : S500 - S501
12345